PharVision Advisers’s Northrim BanCorp NRIM Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIM
VCM
VPM
DLP
PAIM
PharVision Advisers's NRIM Position: Q1 2026 in Review
PharVision Advisers sold out of Northrim BanCorp (NRIM) in Q1 2026, closing a stake of 18,884 shares — an estimated $503K sold.
PharVision Advisers first reported a position in NRIM in Q4 2025 and held it in 1 quarter. The position peaked at $503K in Q4 2025. 161 funds tracked by Wall St. Rank hold NRIM as of Q1 2026.
- PharVision Advisers reported no remaining Northrim BanCorp position as of Q1 2026 after selling out during the quarter.
- PharVision Advisers sold 18,884 Northrim BanCorp shares in Q1 2026, an estimated $503K.
- PharVision Advisers first reported a position in Northrim BanCorp in Q4 2025 and held it in 1 quarter.
- PharVision Advisers's Northrim BanCorp position peaked at $503K in Q4 2025.
- 161 funds tracked by Wall St. Rank held Northrim BanCorp as of Q1 2026.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.